Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 1, Issue 5, 1995, Pages 195-198

  Osborn, Jennifer L ^a,b   Schwartz, Gary G ^c   Smith, David C ^a,b   Bahnson, Robert ^a,b   Day, Roger ^a,d   Trump, Donald L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

1; 25(OH)2D3; calcitriol; Prostate cancer; therapeutics; Vitamin D

Indexed keywords

EID: 0001013226     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/1078-1439(95)00061-5     Document Type: Article

References (24)

1. Cancer statistics
2. Management of prostate cancer
3. Estramustine and vinblastine: Use of PSA as a clinical endpoint for hormone refractory prostate cancer
4. Suramin, an active drug for prostate cancer: Interim observations in a phase 1 trial
5. Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate
6. Prostate cancer and vitamin (hormone) D: A case-control study
7. Vitamin D and prostate cancer: A prediagnostic study with stored sera
8. 3
9. Human prostate cancer cells: Inhibition by vitamin D analogs
10. 3 analog in a squamous cell carcinoma model system
11. 3
12. 3 and actions in human prostate cancer cell lines
13. High-dose vitamin D therapy: Indications, benefits and hazards
14. Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night
15. Optimal two-stage designs for phase II clinical trials
16. Is vitamin D a risk factor for prostate cancer? (Hypothesis)
17. Latent carcinoma of the prostate
18. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation
19. 3 receptors in human epithelial cancer cell lines
20. 3 receptors and human colon adenocarcinoma
21. 3 metabolites
22. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro
23. 3 and prostate cancer cell proliferation in vivo
24. Enhanced antitumor activity of 1,25-dihydroxycholecalciferol by dexamethasone in squamous cell carcinoma (abstract)